GWM
FOMX

Gupta Wealth Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Gupta Wealth Management’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$20K Hold
3,000
– – ﹤0.01% 659
2015
Q4 		$24K Hold
3,000
– – 0.01% 618
2015
Q3 		$22K Hold
3,000
– – 0.01% 668
2015
Q2 		$31K Hold
3,000
– – 0.01% 624
2015
Q1 		$28K Buy
+3,000
New +$26.8K 0.01% 516

Other funds holding FOMX

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Gupta Wealth Management's FOMX Position: Q1 2016 in Review

Gupta Wealth Management held its Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) position steady in Q1 2016 at 3,000 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #659.

Gupta Wealth Management first reported a position in FOMX in Q1 2015 and has held it in 5 quarters since. The position peaked at $31K in Q2 2015. 66 funds tracked by Wall St. Rank hold FOMX as of Q1 2016.

  • Gupta Wealth Management held 3,000 shares of Foamix Pharmaceuticals Ltd. Ordinary Shares worth $20K as of Q1 2016.
  • Gupta Wealth Management left its Foamix Pharmaceuticals Ltd. Ordinary Shares share count unchanged in Q1 2016.
  • Foamix Pharmaceuticals Ltd. Ordinary Shares made up ﹤0.01% of Gupta Wealth Management's portfolio in Q1 2016, its #659 holding.
  • Gupta Wealth Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2015 and has held it in 5 quarters since.
  • Gupta Wealth Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $31K in Q2 2015.
  • 66 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2016.

Based on Gupta Wealth Management's 13F filing for Q1 2016, filed 16 May 2016.